Escape from breast tumor dormancy: The convergence of obesity and menopause.
Escape from breast tumor dormancy: The convergence of obesity and menopause.
复制标题
DOI:
10.1073/pnas.2204758119
复制
发表时间:
2022-10-11
影响因子:
11.1
通讯作者:
中科院分区:
文献类型:
--
作者:
Postmenopausal (PM) obesity is associated with an increased risk of, and a poor prognosis for, breast cancer (BC); however, clinically relevant therapeutic strategies for obesity-associated PM BC are currently nonexistent. We report that PM obesity promotes the escape from tumor dormancy via the early acquisition of the switch to the vascular phenotype (SVP) and initiates aggressive tumor growth via increased neovascularization. Finally, we show that targeting neovascularization via a multikinase angiogenesis inhibitor delayed the obesity-mediated SVP, prolonged tumor latency, reduced tumor frequency, and increased tumor-free survival in obese PM mice. Obesity is associated with an increased risk of, and a poor prognosis for, postmenopausal (PM) breast cancer (BC). Our goal was to determine whether diet-induced obesity (DIO) promotes 1) shorter tumor latency, 2) an escape from tumor dormancy, and 3) an acceleration of tumor growth and to elucidate the underlying mechanism(s). We have developed in vitro assays and PM breast tumor models complemented by a noninvasive imaging system to detect vascular invasion of dormant tumors and have used them to determine whether obesity promotes the escape from breast tumor dormancy and tumor growth by facilitating the switch to the vascular phenotype (SVP) in PM BC. Obese mice had significantly higher tumor frequency, higher tumor volume, and lower overall survival compared with lean mice. We demonstrate that DIO exacerbates mammary gland hyperplasia and neoplasia, reduces tumor latency, and increases tumor frequency via an earlier acquisition of the SVP. DIO establishes a local and systemic proangiogenic and inflammatory environment via the up-regulation of lipocalin-2 (LCN2), vascular endothelial growth factor (VEGF), and basic fibroblast growth factor (bFGF) that may promote the escape from tumor dormancy and tumor progression. In addition, we show that targeting neovascularization via a multitargeted receptor tyrosine kinase inhibitor, sunitinib, can delay the acquisition of the SVP, thereby prolonging tumor latency, reducing tumor frequency, and increasing tumor-free survival, suggesting that targeting neovascularization may be a potential therapeutic strategy in obesity-associated PM BC progression. This study establishes the link between obesity and PM BC and, for the first time to our knowledge, bridges the dysfunctional neovascularization of obesity with the earliest stages of tumor development.
登录
查看更多内容
影响因子:
4.8
作者:
Gunther, EJ;Belka, GK;Chodosh, LA
通讯作者:
Chodosh, LA
DOI:
10.1111/micc.12270
发表时间:
2016-04
期刊:
Microcirculation (New York, N.Y. : 1994)
影响因子:
--
作者:
Fukumura D;Incio J;Shankaraiah RC;Jain RK
通讯作者:
Jain RK
影响因子:
2.8
作者:
Favaro, Elena;Amadori, Alberto;Indraccolo, Stefano
通讯作者:
Indraccolo, Stefano
影响因子:
--
作者:
Campbell NE;Kellenberger L;Greenaway J;Moorehead RA;Linnerth-Petrik NM;Petrik J
通讯作者:
Petrik J
DOI:
10.1073/pnas.97.8.3884
发表时间:
2000-04-11
影响因子:
11.1
作者:
Fang, JM;Shing, Y;Moses, MA
通讯作者:
Moses, MA